The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter

Allergy and Asthma Proceedings

Volumn 31, Issue 1, 2010, Pages 40-48

  Shah, Shailen ^a   White, Martha ^b   Uryniak, Tom ^c   O'Brien, Christopher D ^c  

^a Allergy and Asthma Consultants NJ/PA   (United States)

^b Institute for Asthma and Allergy   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Actuation counter; Asthma; Budesonide; Efficacy; Formoterol; Functionality; pMDI; Safety; Symbicort

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL;

ACTUATION COUNTER; ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ANXIETY; ARTICLE; ASTHMA; CAREGIVER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEVICE; DRUG DELIVERY SYSTEM; DRUG LABELING; DRUG WITHDRAWAL; DYSPHONIA; FEMALE; FEVER; HEADACHE; HUMAN; HYPESTHESIA; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; MUSCLE SPASM; NERVOUSNESS; PATIENT ASSESSMENT; PATIENT SATISFACTION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCHOOL CHILD; SIDE EFFECT; SORE THROAT; SPIROMETRY; THROAT IRRITATION; TOOTH PAIN; TREMOR; URTICARIA; WEIGHT CHANGE;

EID: 76149116536     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Sander N, Fusco-Walkert SJ, Harder JM, et al. Dose counting and the use of pressurized metered-dose inhalers: Running on empty. Ann Allergy Asthma Immunol 97:34 -38, 2006.
2. Guidance for industry: Integration of dose-counting mechanisms into MDI drug products. FDA/Center for Drug Evaluation and Research. Available online at www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ ucm071731.pdf; last accessed September 30, 2009.
3. Ogren RA, Baldwin JL, and Simon RA. How patients determine when to replace their metered-dose inhalers. Ann Allergy Asthma Immunol 75:485- 489, 1995.
4. Rubin BK, and Durotoye L. How do patients determine that their metered-dose inhaler is empty? Chest 126:1134 -1137, 2004.
5. Wasserman RL, Sheth K, Lincourt WR, et al. Real-world assessment of a metered-dose inhaler with integrated dose counter. Allergy Asthma Proc 27:486-492, 2006.
6. Corren J, Korenblat PE, Miller CJ, et al. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clin Ther 29:823- 843, 2007.
7. Morice AH, Hochmuth L, Ekelund J, et al. Comparable longterm safety and efficacy of a novel budesonide/formoterol pressurized metered-dose inhaler versus budesonide/formoterol Turbuhaler in adolescents and adults with asthma. Pulm Pharmacol Ther 21:32-39, 2008.
8. Morice AH, Peterson S, Beckman O, et al. Efficacy and safety of a new pressurised metered-dose inhaler formulation of budesonide/ formoterol in children with asthma: A superiority and therapeutic equivalence study. Pulm Pharmacol Ther 21:152-159, 2008.
9. Noonan M, Rosenwasser LJ, Martin P, et al. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: A randomised clinical trial. Drugs 66:2235-2254, 2006.
10. Peters SP, Prenner BM, Mezzanotte WS, et al. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. Allergy Asthma Proc 29:499 -516, 2008.
11. Sheth K, Wasserman RL, Lincourt WR, et al. Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction. Int J Clin Pract 60:1218 -1224, 2006.
12. Milgrom H, Bender B, Ackerson L, et al. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 98:1051-1057, 1996.
13. Stern L, Berman J, Lumry W, et al. Medication compliance and disease exacerbation in patients with asthma: A retrospective study of managed care data. Ann Allergy Asthma Immunol 97:402- 408, 2006.
14. Smith JR, Mildenhall S, Noble M, et al. Clinician-assessed poor compliance identifies adults with severe asthma who are at risk of adverse outcomes. J Asthma 42:437- 445, 2005.
15. Bender BG, Long A, Parasuraman B, et al. Factors influencing patient decisions about the use of asthma controller medication. Ann Allergy Asthma Immunol 98:322-328, 2007.
16. Holt S, Holt A, Weatherall M, et al. Metered dose inhalers: A need for dose counters. Respirology 10:105-106, 2005.
17. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis 146:1559 -1564, 1992.
18. Berg J, Dunbar-Jacob J, and Rohay JM. Compliance with inhaled medications: The relationship between diary and electronic monitor. Ann Behav Med 20:36 -38, 1998.
19. Jones JS, Holstege CP, Riekse R, et al. Metered-dose inhalers: Do emergency health care providers know what to teach? Ann Emerg Med 26:308 -311, 1995.
20. Cain WT, and Oppenheimer JJ. The misconception of using floating patterns as an accurate means of measuring the contents of metered-dose inhaler devices. Ann Allergy Asthma Immunol 87:417- 419, 2001.